Post-earnings recap
Reported
Wed, Feb 25, 2026
EPS actual
$0.20
EPS est.
—
EPS surprise
—
1-day move
+1.03%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ADMA Biologics Inc's earnings report shows a positive EPS of $0.20, but revenue details were not disclosed. The stock reacted positively, increasing by 1.03%. This suggests that investors are encouraged by the company's performance despite the lack of revenue information and guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.20 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a sense of cautious optimism about future growth. They emphasized their commitment to innovation and market expansion.
Management highlighted the importance of ongoing product development.
They expressed confidence in their strategic initiatives moving forward.
What the market is pricing for the move.
Implied Move
±18.2%
ATM IV
1.0%
30d HV
100.9%